Liver failure in human immunodeficiency virus - Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy.

@article{MarchanLopez2016LiverFI,
  title={Liver failure in human immunodeficiency virus - Hepatitis C virus coinfection treated with sofosbuvir, ledipasvir and antiretroviral therapy.},
  author={Alvaro Marchan-Lopez and Lourdes Dom{\'i}nguez-Dom{\'i}nguez and Pablo Kessler-Saiz and Miguel Eduardo Jarrin-Estupi{\~n}an},
  journal={Journal of hepatology},
  year={2016},
  volume={64 3},
  pages={752-3}
}
Fig. 1. Temporal evolution of serum bilirubin level and MELD score. To the Editor: In their manuscript Liver toxicity associated with sofosbuvir, an NS5A inhibitor, and ribavirin use, Dyson et al. report two cases of liver toxicity related to treatment with sofosbuvir and NS5A inhibitors in patients with decompensated cirrhosis due to hepatitis C (HCV). There are no previous known cases of hepatotoxicity or drug-induced liver injury due to the use of sofosbuvir or NS5A inhibitors and, thus far… CONTINUE READING